2 Min Read |
SEOUL (Reuters) – South Korean cosmetics and pharmaceuticals contract manufacturer Korea Kolmar Co (161890.KS) beat out private equity firms for a deal to buy domestic health foods and drugmaker CJ HealthCare for $1.2 billion, sending its shares soaring on Wednesday.
Korea Kolmar said in a regulatory filing on Tuesday it agreed to…